BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11296312)

  • 1. Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.
    Rowland L; Bustillo JR; Lauriello J
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):121-30. PubMed ID: 11296312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
    Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.
    Steel RM; Bastin ME; McConnell S; Marshall I; Cunningham-Owens DG; Lawrie SM; Johnstone EC; Best JJ
    Psychiatry Res; 2001 May; 106(3):161-70. PubMed ID: 11382538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
    Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.
    Brugger S; Davis JM; Leucht S; Stone JM
    Biol Psychiatry; 2011 Mar; 69(5):495-503. PubMed ID: 21145039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM; Lenkinski RE; Gur RE; Gur RC
    Neuropsychopharmacology; 1999 Feb; 20(2):131-40. PubMed ID: 9885793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
    Fukuzako H; Takeuchi K; Hokazono Y; Fukuzako T; Yamada K; Hashiguchi T; Obo Y; Ueyama K; Takigawa M; Fujimoto T
    Psychiatry Res; 1995 Nov; 61(4):193-200. PubMed ID: 8748464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.
    Omori M; Murata T; Kimura H; Koshimoto Y; Kado H; Ishimori Y; Ito H; Wada Y
    Psychiatry Res; 2000 May; 98(3):155-62. PubMed ID: 10821998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
    Nudmamud S; Reynolds LM; Reynolds GP
    Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology.
    Sanches RF; Crippa JA; Hallak JE; Araújo D; Zuardi AW
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Jun; 59(3):145-52. PubMed ID: 15286836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.
    Heimberg C; Komoroski RA; Lawson WB; Cardwell D; Karson CN
    Psychiatry Res; 1998 Aug; 83(2):105-15. PubMed ID: 9818736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.